Research Studies
Back to Results
Effects of low-dose levetiracetam on clinical symptoms, cognition and hippocampal hyperactivity in patients with schizophrenia
Details
Age
Adult
Phase
Not Applicable - Describes studies without FDA-defined phases, including studies of devices or behavioral interventions.
Type of Study
Treatment
Locations
Anschutz Health and Wellness
Outpatient CTRC
UCD Anschutz Health & Wellness Center
University of Colorado Hospital
Principal Investigator
Jason Tregellas, PhD
Study ID
Protocol Number: 13-1495
More information available at ClinicalTrials.gov: NCT02647437
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers